Headquartered in Kansas City
816-679-3188
Established in 2005

MicroJek brings an exclusive line of microinjection needles to the cellular research market. The company produces the world’s smallest commercially-available microinjection needles, a nanotechnology product.

Mike Jackson was referred to KCSourceLink by the KC Regional SBA office in April, 2005.  He wanted to network with other business people to position MicroJek within the high-tech, biotech community in the KC region and was also interested in developing angel investor contacts.

“KCSourceLink’s help has been instrumental in my successfully networking into resources and other influential business leaders in Kansas and Missouri ,” Jackson says. 

These contacts also helped make it possible for Jackson to be a presenter at the November, 2005 Nanotechnology at the Interface with Life Sciences Research conference in Kansas City MO.  His presentation topic:  “Microinjection & Micropipettes,” a lecture discussing micro-injection as a technique for delivering nano particles for use in molecular biology.

One application of microinjection is in molecular biology, where it is used specifically to deliver nano particles into individual cells and cell nuclei.  This is used in the study of genetic, cellular alteration.  Such techniques are used to test & correct genetic & epi-genetic disorders - with real world applications in investigating over 4000 diseases that include diabetes, Parkinson’s, cancer, sickle cell anemia, and Alzheimer’s. 

MicroJek’s products are germane in the manipulation and study of stem cells, whose characteristics are seen to have vital roles in the treatment in a large number of deadly or debilitating illnesses.  Specifically, the MicroJek’s StemJek needle is designed specifically to inject macro molecules into stem cells.  StemJek has been shown, empirically, to increase the success rates of microinjection techniques in stem cells by as much as 231%.

Recently, MicroJek’s products have been used in mouse RNA experiments at MIT and KUMed / Tufts University.  As a result of efforts at KU labs, a paper by Dr. Susan Barrett was published in the June 2007 issue of Biology of Reproduction.  

The company has developed and continues to develop specialty needles for projects at the University of Rochester, MIT, and Harvard. MicroJek has also assisted in classroom experiments at “Frontiers in Reproduction,” a specialized workshop at the Marine Biology Lab in Woods Hole, MA.

“It is our goal to make the world's best micro-needles as well as provide expert techniques to innovative researchers everywhere.  And, with our top-tier partners, MicroJek continues to design and produce industry-revolutionizing products in molecular and reproductive biology,” states Jackson.

Inquiries can be submitted to info@microjek.com. The company's website is www.microjek.com.